Procter & Gamble Health has appointed Shashank Srowthy as its new Chief Financial Officer, effective October 1, 2025. Srowthy succeeds Lokesh Chandak, who resigned to take on a new role within P&G as Senior Director – Finance & Accounting for Feminine Care in Asia Pacific Enterprise Markets, Middle East, and Africa.
Srowthy brings 14 years of extensive finance experience to the role, having worked in various capacities across India, Dubai, and Singapore since joining P&G in 2011. A graduate with a bachelor’s degree in Electronics & Telecommunication Engineering from Pune University and a master’s in management studies from Jamnalal Bajaj Institute of Management Studies, he has delivered exceptional results for multiple P&G businesses.
The company announced that Srowthy will serve as Additional Director until the upcoming Annual General Meeting. His appointment as Executive Director is pending approval from the Central Government under Section 196 of the Companies Act, 2013, and shareholder consent, as stated in a stock exchange filing.
ALSO READ: REIMAGINING PUBLIC FINANCE: HOW SMARTER SPENDING CAN DRIVE DEVELOPMENT
This leadership transition aligns with P&G’s strategy to leverage internal talent for key roles. Chandak’s move to a senior position within the company reflects P&G’s commitment to fostering career growth and mobility.
Srowthy’s diverse experience and proven track record position him to drive financial excellence for Procter & Gamble Health as it continues to expand its footprint in the healthcare sector.
